// App-Quantinova.ai

PB1486 : TRIAL IN PROGRESS: QUANTIFYING THE HUMANISTIC AND SOCIOECONOMIC BURDEN OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE COMMODORE BURDEN OF ILLNESS STUDY

Researchers

Presenter

  • Roger James Hampton

Principal Investigators

  • Pablo Katz

  • Aijing Shang

  • Harpal Dhillon

  • Hayley Hubberstey

Medical Centers

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • HCD Economics, The Innovation Centre,Daresbury, Cheshire,United Kingdom

Locations

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

Biomarkers

  • N/A

Drug/Treatment

  • Eculizumab

  • Immunol

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved